Ashlee V. Moses Vaccine and Gene Therapy Institute Oregon Health and Science University Biography Publications Institution JoVE Articles Ashlee V. Moses has not added a biography. If you are Ashlee V. Moses and would like to personalize this page please email our Author Liaison for assistance. Publications The Heme Metabolite Carbon Monoxide Facilitates KSHV Infection by Inhibiting TLR4 Signaling in Endothelial Cells Frontiers in Microbiology. 2017 | Pubmed ID: 28421060 Kaposi Sarcoma Herpesvirus Induces HO-1 During De Novo Infection of Endothelial Cells Via Viral MiRNA-Dependent and -Independent Mechanisms MBio. Jun, 2015 | Pubmed ID: 26045540 Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin The Journal of Infectious Diseases. Oct, 2015 | Pubmed ID: 25821226 CXCR7 Expression Disrupts Endothelial Cell Homeostasis and Causes Ligand-dependent Invasion Cell Adhesion & Migration. 2014 | Pubmed ID: 24710021 Comparative Study of Four Immortalized Human Brain Capillary Endothelial Cell Lines, HCMEC/D3, HBMEC, TY10, and BB19, and Optimization of Culture Conditions, for an in Vitro Blood-brain Barrier Model for Drug Permeability Studies Fluids and Barriers of the CNS. Nov, 2013 | Pubmed ID: 24262108 Aberrant Proliferation in CXCR7+ Endothelial Cells Via Degradation of the Retinoblastoma Protein PloS One. 2013 | Pubmed ID: 23894550 A Comparative Mutational Analysis of HIV-1 Vpu Subtypes B and C for the Identification of Determinants Required to Counteract BST-2/Tetherin and Enhance Viral Egress Virology. Jul, 2013 | Pubmed ID: 23582304 IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling PLoS Pathogens. Jan, 2013 | Pubmed ID: 23300459 CD31 Immunohistochemical Staining in Kaposi Sarcoma Archives of Pathology & Laboratory Medicine. Nov, 2012 | Pubmed ID: 23106575 Ubiquitination of BST-2 Protein by HIV-1 Vpu Protein Does Not Require Lysine, Serine, or Threonine Residues Within the BST-2 Cytoplasmic Domain The Journal of Biological Chemistry. Apr, 2012 | Pubmed ID: 22383521 Viral Takeover of the Host Ubiquitin System Frontiers in Microbiology. 2011 | Pubmed ID: 21847386 Kaposi's Sarcoma and Human Dermal Microvascular Endothelial Cells Infected with Kaposi's Sarcoma-associated Herpesvirus Express CCL21 Journal of Dermatological Science. Feb, 2011 | Pubmed ID: 21176872 Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation Translational Biomedicine. 2010 | Pubmed ID: 23082307 The Great Escape: Viral Strategies to Counter BST-2/tetherin PLoS Pathogens. May, 2010 | Pubmed ID: 20485522 Molecular Mechanism of BST2/tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-associated Herpesvirus Journal of Virology. Oct, 2009 | Pubmed ID: 19605472 The Inflammatory Component of Kaposi Sarcoma Experimental and Molecular Pathology. Oct, 2009 | Pubmed ID: 19591823 Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin Via a {beta}TrCP-dependent Mechanism Journal of Virology. Aug, 2009 | Pubmed ID: 19515779 Characterization of C-Kit Expression and Activation in KSHV-infected Endothelial Cells Virology. Aug, 2009 | Pubmed ID: 19501868 Remodeling of Endothelial Adherens Junctions by Kaposi's Sarcoma-associated Herpesvirus Journal of Virology. Oct, 2008 | Pubmed ID: 18667499 Pathology of Rituximab-induced Kaposi Sarcoma Flare BMC Clinical Pathology. Jul, 2008 | Pubmed ID: 18651955 Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing Journal of Virology. Jul, 2008 | Pubmed ID: 18448536 Insulin-like Growth Factor II Receptor-mediated Intracellular Retention of Cathepsin B is Essential for Transformation of Endothelial Cells by Kaposi's Sarcoma-associated Herpesvirus Journal of Virology. Aug, 2007 | Pubmed ID: 17507477 Kaposi Sarcoma Herpesvirus K5 Removes CD31/PECAM from Endothelial Cells Blood. Sep, 2006 | Pubmed ID: 16601245 Functional Genomics and the Development of Pathogenesis-targeted Therapies for Kaposi's Sarcoma Pharmacogenomics. Apr, 2005 | Pubmed ID: 16013955 Novel Cellular Genes Essential for Transformation of Endothelial Cells by Kaposi's Sarcoma-associated Herpesvirus Cancer Research. Jun, 2005 | Pubmed ID: 15958552 Increased Efficiency of Phorbol Ester-induced Lytic Reactivation of Kaposi's Sarcoma-associated Herpesvirus During S Phase Journal of Virology. Feb, 2005 | Pubmed ID: 15681463 Human Immunodeficiency Virus (HIV) Type 1 Vpu Induces the Expression of CD40 in Endothelial Cells and Regulates HIV-induced Adhesion of B-lymphoma Cells Journal of Virology. May, 2004 | Pubmed ID: 15078922 Kaposi Sarcoma-associated Herpesvirus (KSHV) Induces Heme Oxygenase-1 Expression and Activity in KSHV-infected Endothelial Cells Blood. May, 2004 | Pubmed ID: 14726403 A Functional Genomics Approach to Kaposi's Sarcoma Annals of the New York Academy of Sciences. Dec, 2002 | Pubmed ID: 12538164 Kaposi's Sarcoma-associated Herpesvirus-induced Upregulation of the C-kit Proto-oncogene, As Identified by Gene Expression Profiling, is Essential for the Transformation of Endothelial Cells Journal of Virology. Aug, 2002 | Pubmed ID: 12134042 An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus Shane C. McAllister1, Ryan S. Hanson1, Kyleen N. Grissom1, Sara Botto2, Ashlee V. Moses2 1Division of Pediatric Infectious Diseases, University of Minnesota Medical School, 2Vaccine and Gene Therapy Institute, Oregon Health and Science University JoVE 54828 Biology
An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus Shane C. McAllister1, Ryan S. Hanson1, Kyleen N. Grissom1, Sara Botto2, Ashlee V. Moses2 1Division of Pediatric Infectious Diseases, University of Minnesota Medical School, 2Vaccine and Gene Therapy Institute, Oregon Health and Science University JoVE 54828 Biology